Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients Oct 21, 2019
Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP Aug 21, 2019
CORRECTING and REPLACING Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymes Aug 12, 2019
Propanc Biopharma Completes Development of Bio-analytical Assay Method to Quantify PRP’s Active Ingredients in Preparation for First-In-Human Study Aug 8, 2019
Propanc Biopharma Provides Update on Preparation of PRP for Clinical Trial Application Submission and Recently Completed Reverse Stock Split Jul 15, 2019
